Grace Therapeutics GRCE
NASDAQ GRCE
$2.11 -0.01 (-0.47%)
At close: Sep 29, 2026 · 4:00 PM EDT

Grace Therapeutics (GRCE) Operating Expenses (2019 - 2026)

Updated

Grace Therapeutics (GRCE) recorded Operating Expenses of $2.38 million in fiscal Q1 2027 (quarter ended Jun 30, 2026), down 22.8% from $3.09 million a year earlier and down 20.8% from the prior quarter.

Analysis

Grace Therapeutics (GRCE) Operating Expenses (2019 - 2026) Analysis & Trends

On a TTM basis, Grace Therapeutics' Operating Expenses came in at $10.37 million as of Jun 30, 2026, down 30.0% year-over-year; for FY2026 (ended Mar 31, 2026), it came in at $11.08 million, down 33.6% from FY2025.

  • Annual Operating Expenses has a five-year compound annual growth rate of 2.7% (FY2021 to FY2026).
  • Across earlier fiscal years, Operating Expenses came in at $16.68 million in FY2025 (+29.8%), $12.85 million in FY2024 (-26.9%), $17.59 million in FY2023 (+18.6%) and $14.82 million in FY2022 (+52.9%).
  • The fiscal Q1 2027 figure is the lowest quarterly Operating Expenses since fiscal Q2 2024.
  • On a year-over-year basis, Operating Expenses has declined for six consecutive quarters, with growth averaging 0.3% over the last eight quarters.
  • Peak year-over-year performance for Operating Expenses in the last five years was growth of 130.9% in fiscal Q2 2025, against a decline of 57.9% in fiscal Q2 2024 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at $3.01 million (Q4 2026), $2.45 million (Q3 2026) and $2.53 million (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 10.12 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 10.56 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -9.70 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 18.20 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 2.09 Bn
10 Grace Therapeutics 34.50 Mn 34.50 Mn - 2.38 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.38 Mn
Mar 31, 2026 3.01 Mn
Dec 31, 2025 2.45 Mn
Sep 30, 2025 2.53 Mn
Jun 30, 2025 3.09 Mn
Mar 31, 2025 3.18 Mn
Dec 31, 2024 3.70 Mn
Sep 30, 2024 4.83 Mn
Jun 30, 2024 4.96 Mn
Mar 31, 2024 3.26 Mn
Dec 31, 2023 3.04 Mn
Sep 30, 2023 2.09 Mn
Jun 30, 2023 4.45 Mn
Mar 31, 2023 4.07 Mn
Dec 31, 2022 4.04 Mn
Sep 30, 2022 4.97 Mn
Jun 30, 2022 4.51 Mn
Mar 31, 2022 4.15 Mn
Dec 31, 2021 3.99 Mn
Sep 30, 2021 3.54 Mn
API Access

Grace Therapeutics Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=GRCE&period=max&api_key=YOUR_API_KEY